Qube Research & Technologies LTD Merck & Co., Inc. Transaction History

Qube Research & Technologies LTD

  • $72.9 Billion
  • Q4 2024

A detailed history of Qube Research & Technologies LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 4,370,461 shares of MRK stock, worth $391 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
4,370,461
Previous 4,172,845 4.74%
Holding current value
$391 Million
Previous $474 Million 8.25%
% of portfolio
0.6%
Previous 0.72%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$96.31 - $114.76 $19 Million - $22.7 Million
197,616 Added 4.74%
4,370,461 $435 Million
Q3 2024

Nov 14, 2024
SELL
$111.15 - $128.97 $11.4 Million - $13.2 Million
-102,238 Reduced 2.39%
4,172,845 $474 Million
Q2 2024

Aug 14, 2024
BUY
$123.8 - $132.96 $363 Million - $390 Million
2,934,358 Added 218.86%
4,275,083 $529 Million
Q1 2024

May 14, 2024
SELL
$113.24 - $131.95 $99.4 Million - $116 Million
-877,344 Reduced 39.55%
1,340,725 $177 Million
Q4 2023

Feb 13, 2024
BUY
$100.18 - $109.02 $101 Million - $109 Million
1,003,895 Added 82.68%
2,218,069 $242 Million
Q3 2023

Nov 13, 2023
BUY
$102.95 - $114.33 $85.5 Million - $94.9 Million
830,027 Added 216.07%
1,214,174 $125 Million
Q2 2023

Aug 14, 2023
SELL
$108.61 - $118.38 $31.3 Million - $34.1 Million
-287,820 Reduced 42.83%
384,147 $44.3 Million
Q1 2023

May 15, 2023
BUY
$102.94 - $114.86 $68.3 Million - $76.2 Million
663,314 Added 7665.71%
671,967 $71.5 Million
Q4 2022

Feb 14, 2023
SELL
$87.44 - $112.11 $50.4 Million - $64.7 Million
-576,696 Reduced 98.52%
8,653 $959,000
Q3 2022

Nov 14, 2022
SELL
$84.53 - $94.96 $41.9 Million - $47.1 Million
-495,887 Reduced 45.86%
585,349 $50.4 Million
Q2 2022

Aug 15, 2022
BUY
$83.49 - $94.64 $55.2 Million - $62.6 Million
661,374 Added 157.52%
1,081,236 $98.6 Million
Q1 2022

May 09, 2022
BUY
$73.51 - $82.4 $16.6 Million - $18.6 Million
225,767 Added 116.32%
419,862 $34.5 Million
Q4 2021

Feb 01, 2022
BUY
$72.28 - $90.54 $14 Million - $17.6 Million
194,095 New
194,095 $14.9 Million
Q3 2021

Nov 12, 2021
SELL
$71.68 - $78.83 $809,482 - $890,227
-11,293 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$70.31 - $77.77 $794,010 - $878,256
11,293 New
11,293 $878,000
Q1 2021

May 14, 2021
SELL
$68.86 - $81.11 $3.36 Million - $3.96 Million
-48,777 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$71.77 - $79.65 $23.6 Million - $26.2 Million
-329,045 Reduced 87.09%
48,777 $3.99 Million
Q3 2020

Nov 12, 2020
BUY
$73.18 - $82.95 $26.2 Million - $29.7 Million
357,964 Added 1802.62%
377,822 $31.3 Million
Q2 2020

Aug 14, 2020
BUY
$70.42 - $80.13 $1.4 Million - $1.59 Million
19,858 New
19,858 $1.54 Million
Q1 2020

May 15, 2020
SELL
$63.36 - $87.82 $4.79 Million - $6.64 Million
-75,612 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$77.58 - $87.54 $5.87 Million - $6.62 Million
75,612 New
75,612 $6.88 Million
Q3 2019

Nov 13, 2019
SELL
$76.08 - $82.93 $2.36 Million - $2.57 Million
-31,002 Closed
0 $0
Q2 2019

Aug 02, 2019
SELL
$69.84 - $81.59 $4.49 Million - $5.24 Million
-64,275 Reduced 67.46%
31,002 $2.6 Million
Q1 2019

May 15, 2019
BUY
$69.58 - $79.36 $6.18 Million - $7.05 Million
88,833 Added 1378.54%
95,277 $7.92 Million
Q4 2018

Feb 14, 2019
SELL
$65.24 - $75.71 $4.91 Million - $5.69 Million
-75,187 Reduced 92.11%
6,444 $492,000
Q3 2018

Nov 14, 2018
BUY
$57.69 - $67.84 $4.71 Million - $5.54 Million
81,631 New
81,631 $5.79 Million
Q2 2018

Aug 14, 2018
SELL
$50.83 - $59.72 $1.87 Million - $2.2 Million
-36,861 Closed
0 $0
Q1 2018

May 14, 2018
BUY
$50.96 - $59.23 $1.88 Million - $2.18 Million
36,861 New
36,861 $2.01 Million

Others Institutions Holding MRK

# of Institutions
3,952
Shares Held
1.94B
Call Options Held
16M
Put Options Held
15M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $227B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email